Sacituzumab Govitecan Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 180 mg

Reference Brands: Trodelvy (USA/EU)

Category: Oncology Cancer Care

Product Description:

Sacituzumab govitecan is a targeted anticancer medicine used for the treatment of certain advanced or metastatic cancers. It is an antibody–drug conjugate designed to deliver chemotherapy directly to cancer cells. The drug consists of a monoclonal antibody that targets the Trop-2 protein, which is commonly found on the surface of many tumor cells, combined with a topoisomerase inhibitor that helps destroy cancer cells. By binding to Trop-2 and releasing the cytotoxic agent inside the tumor, sacituzumab govitecan helps reduce tumor growth while focusing treatment on cancer cells.

This therapy is used in patients with metastatic triple-negative breast cancer who have previously received other treatments. It is also approved for patients with metastatic hormone receptor-positive, HER2-negative breast cancer that has progressed after prior therapies. In addition, sacituzumab govitecan is used in certain cases of metastatic urothelial cancer when other treatment options have been used.

Because of its targeted delivery system, sacituzumab govitecan represents an important advancement in modern oncology treatments. It provides an additional option for patients with difficult-to-treat cancers and helps improve disease management in advanced stages of these conditions.